Corticosteroid Sparing Effects of Treatment With Guselkumab in Patients With Moderate to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results Through Week 44

被引：0

作者：

Bressler, Brian ^{[1
]}

Allegretti, Jessica R. ^{[2
]}

Rubin, David T. ^{[3
]}

Shipitofsky, Nicole ^{[4
]}

Huang, Kuan-Hsiang G. ^{[4
]}

Germinaro, Matthew ^{[4
]}

Wilson, Rebbecca ^{[5
]}

Zhang, Hongyan ^{[4
]}

Armuzzi, Alessandro ^{[6
]}

Fishman, Sigal ^{[7
]}

Wang, Yufang ^{[8
]}

Panes, Julian ^{[9
]}

Lichtenstein, Gary R. ^{[10
]}

Peyrin-Biroulet, Laurent ^{[11
,12
]}

机构：

[1] Univ British Columbia, IBD Ctr BC, Vancouver, BC, Canada

[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA

[3] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA

[4] Janssen Res & Dev, Spring House, PA USA

[5] Janssen Res & Dev LLC, Spring House, PA USA

[6] IRCCS Humanitas Res Hosp, Milan, Italy

[7] Sourasky Med Ctr, Tel Aviv, Israel

[8] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[9] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Barcelona, Catalonia, Spain

[10] Univ Penn, Perelman Ctr Adv Med, Philadelphia, PA USA

[11] Nancy Univ Hosp, INFINY Inst, FHU CURE, INSERM NGERE, Vandoeuvre Les Nancy, Lorraine, France

[12] McGill Univ Hlth Ctr, Montreal, PQ, Canada

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期

关键词：

D O I：

10.14309/01.ajg.0001034976.21441.52

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1402

引用

页码：S1002 / S1002

页数：1

共 50 条

[21] QUASAR Induction Study 1 Cumulative Response to Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis
Peyrin-Biroulet, L.
Rubin, D.
Lichtenstein, G.
Shipitofsky, N.
Huang, K. H.
Germinaro, M.
Wilson, R.
Zhang, H.
DuVall, G. A.
Cao, Q.
Allegretti, J.
Feagan, B.
Hisamatsu, T.
Panes, J.
Dignass, A.
Bressler, B.
Sands, B.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 624 - 625
[22] QUASAR Induction Study 1 Cumulative Response to Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis
Sands, Bruce E.
Rubin, David T.
Lichtenstein, Gary
Shipitofsky, Nicole
Huang, Kuan-Hsiang
Germinaro, Matthew
Wilson, Rebbecca
Zhang, Hongyan
DuVall, Aaron
Cao, Qian
Allegretti, Jessica R.
Feagan, Brian G.
Peyrin-Biroulet, Laurent
Hisamatsu, Tadakazu
Panes, Julian
Dignass, Axel
Bressler, Brian
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S526 - S527
[23] Guselkumab improves abdominal pain and bowel urgency symptoms in patients with moderately to severely active ulcerative colitis: Results from the phase 3 QUASAR induction study
Rubin, D.
Panes, J.
Feagan, B.
Yarandi, S.
Huang, K. H.
Germinaro, M.
Han, C.
Miao, Y.
Zhang, H.
Qiu, Y.
Klopocka, M.
Duvall, G.
Lichtenstein, G.
Hisamatsu, T.
Bressler, B.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1816 - I1817
[24] Guselkumab Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the QUASAR Phase 3 Induction Study
Bressler, Brian
Feagan, Brian G.
Panes, Julian
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Pandya, Dwiti
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Lateef, Syed
Petroniene, Rima
Rayyan, Yaser
Peyrin-Biroulet, Laurent
Rubin, David T.
Hisamatsu, Tadakazu
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S807 - S808
[25] Guselkumab Improves Abdominal Pain and Bowel Urgency Symptoms in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study
Rubin, David T.
Panes, Julian
Feagan, Brian G.
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Qiu, Yun
Klopocka, Maria
Duvall, George
Lichtenstein, Gary R.
Hisamatsu, Tadakazu
Bressler, Brian
Peyrin-Biroulet, Laurent
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S677 - S677
[26] Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
Rubin, David T.
Allegretti, Jessica R.
Panes, Julian
Shipitofsky, Nicole
Yarandi, Shadi S.
Huang, Kuan-Hsiang Gary
Germinaro, Matthew
Wilson, Rebbecca
Zhang, Hongyan
Johanns, Jewel
Feagan, Brian G.
Hisamatsu, Tadakazu
Lichtenstein, Gary R.
Bressler, Brian
Peyrin-Biroulet, Laurent
Sands, Bruce E.
QUASAR Study Grp
LANCET, 2025, 405 (10472): : 33 - 49
[27] Guselkumab efficacy and safety in East Asian participants with moderate to severely active Ulcerative Colitis: Subgroup analysis of the Phase 2b/3 QUASAR induction and maintenance studies
Chen, B.
Ye, B. D.
Cao, Q.
Hirai, F.
Saruta, M.
Chen, M.
Pelak, S.
Shipitofsky, N.
Wahking, B.
Zhuo, J.
Hisamatsu, T.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2085 - I2086
[28] Corticosteroid-Sparing Effect in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab Maintenance Therapy
Laharie, David
Siegel, Corey A.
Samaan, Karen
Fischer, Deborah
Morris, Nathan
Redondo, Isabel
Dulai, Parambir S.
Jairath, Vipul
Gisbert, Javier P.
Matsuoka, Katsuyoshi
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S635 - S635
[29] CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY
Laharie, D.
Siegel, C. A.
Samaan, K.
Fisher, D. A.
Morris, N.
Redondo, I.
Dulai, P. S.
Jairath, V.
Gisbert, J. P.
Matsuoka, K.
Orlando, A.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S163 - S164
[30] Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis
Reinisch, Walter
Loftus Jr, Edward, V
Schreiber, Stefan
Rubin, David T.
Louis, Edouard
Hecht, Patrick M.
Barrachina, Elena Marced
Kalabic, Jasmina
Vladea, Ramona
Sharma, Dolly
Duan, Weijiang Rachel
Zhang, Yafei
Panaccione, Remo
JOURNAL OF CROHNS & COLITIS, 2025, 19 (04):

← 1 2 3 4 5 →